Survival Outcomes of Early-Stage Hormone Receptor-Positive Breast Cancer in Elderly Women

被引：0
|
作者：
Apoorve Nayyar
Paula D. Strassle
Kathleen Iles
Danielle Jameison
Jihane Jadi
Kandace P. McGuire
Kristalyn K. Gallagher
机构：
[1] University of Iowa Hospitals and Clinics,General Surgery Resident, Department of Surgery
[2] The University of North Carolina at Chapel Hill,Department of Surgery
[3] University of North Carolina at Chapel Hill,Department of Epidemiology, Gillings School of Global Public Health
[4] VCU School of Medicine,Department of Surgery
[5] Virginia Commonwealth University,Massey Cancer Center
来源：
Annals of Surgical Oncology | 2020年 / 27卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：4853 / 4860
页数：7
相关论文
共 50 条
  • [21] Outcome of adjuvant chemotherapy in elderly patients with early-stage, hormone receptor-positive, HER-2-negative breast cancer
    Ma, Sung Jun
    Oladeru, Oluwadamilola T.
    Singh, Anurag K.
    [J]. BREAST JOURNAL, 2020, 26 (10): : 2026 - 2030
  • [22] Effect of omission of surgery on survival in patients aged 80 years and older with early-stage hormone receptor-positive breast cancer
    de Boer, A. Z.
    de Glas, N. A.
    Marang-van De Mheen, P. J.
    Dekkers, O. M.
    Siesling, S.
    de Munck, L.
    de Ligt, K. M.
    Liefers, G. J.
    Portielje, J. E. A.
    Bastiaannet, E.
    [J]. BRITISH JOURNAL OF SURGERY, 2020, 107 (09) : 1145 - 1153
  • [23] Prognostic Tests in Early-Stage Hormone Receptor-Positive Breast Cancer: An Opportunity to Refine Personalized Cancer Care
    LeVasseur, Nathalie
    Gelmon, Karen A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (10) : 1816 - +
  • [24] Impact of tamoxifen on breast recurrence, cosmesis, complications, and survival in estrogen receptor-positive early-stage breast cancer
    Fowble, B.
    Fein, D.A.
    Hanlon, A.L.
    Eisenberg, B.L.
    Hoffman, J.P.
    Sigurdson, E.R.
    Daly, M.B
    Goldstein, L.J.
    [J]. International Journal of Radiation Oncology, Biology, Physics, 1996, 35 (04):
  • [25] Adherence to endocrine therapy in patients with hormone receptor-positive early-stage breast cancer: a retrospective study
    Yan, Yi-Dan
    Fu, Jie
    Gu, Zhi-Chun
    Lu, Jin-Song
    Su, Ying-Jie
    Lin, Hou-Wen
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2023, 45 (01) : 184 - 190
  • [26] The impact of tamoxifen on breast recurrence, cosmesis, complications, and survival in estrogen receptor-positive early-stage breast cancer
    Fowble, B
    Fein, DA
    Hanlon, AL
    Eisenberg, BL
    Hoffman, JP
    Sigurdson, ER
    Daly, MB
    Goldstein, LJ
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1996, 35 (04): : 669 - 677
  • [27] Neratinib for the treatment of early-stage, hormone receptor-positive, HER2-overexpressed breast cancer
    Jerez, Yolanda
    Herrero, Blanca
    Arregui, Marta
    Moron, Blanca
    Martin, Miguel
    Echavarria, Isabel
    [J]. FUTURE ONCOLOGY, 2020, 16 (17) : 1165 - 1177
  • [28] Adherence to endocrine therapy in patients with hormone receptor-positive early-stage breast cancer: a retrospective study
    Yi-Dan Yan
    Jie Fu
    Zhi-Chun Gu
    Jin-Song Lu
    Ying-Jie Su
    Hou-Wen Lin
    [J]. International Journal of Clinical Pharmacy, 2023, 45 : 184 - 190
  • [29] Trends and outcomes of systemic therapy in hormone receptor-positive early-stage male breast cancer: A propensity score analysis.
    Yu, Liuwen
    Zeng, Bangwei
    Chen, Minyan
    Huang, Meng
    Guo, Wenhui
    Chen, Lili
    Lin, Yuxiang
    Li, Jing
    Li, Yan
    Fu, Fangmeng
    Jacobs, Lisa K.
    Wang, Chuan
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [30] Characterization of Clinical Symptoms by Race Among Women With Early-Stage, Hormone Receptor-Positive Breast Cancer Before Starting Chemotherapy
    Hu, Xin
    Chehal, Puneet K.
    Kaplan, Cameron
    Krukowski, Rebecca A.
    Lan, Roy H.
    Stepanski, Edward
    Schwartzberg, Lee
    Vidal, Gregory
    Graetz, Ilana
    [J]. JAMA NETWORK OPEN, 2021, 4 (06) : E2112076
12345